Drug maker Rohto plans clinical trials in Hong Kong as OASES' partner
Japanese pharmaceutical firm Rohto is partnering with Hong Kong under the OASES initiative to conduct clinical trials.
Japanese pharmaceutical firm Rohto is partnering with Hong Kong under the OASES initiative to conduct clinical trials.